Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Apply
KST-6051
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step